Blueberries Medical Corp. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CAD 0.104856 million compared to CAD 0.135981 million a year ago. Net loss was CAD 0.358244 million compared to CAD 0.428623 million a year ago.
For the nine months, sales was CAD 0.178397 million compared to CAD 0.173886 million a year ago. Net loss was CAD 1.47 million compared to CAD 1.29 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. Diluted loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.